N-3 PUFA-enriched diet delays the occurrence of cancer cachexia in rat with peritoneal carcinosis

Nutrition and Cancer

Volumn 62, Issue 3, 2010, Pages 343-350

  Dumas, Jean François ^a,b   Goupille, Caroline ^a,b   Pinault, Michelle ^a,b   Fandeur, Ludivine ^a,b   Bougnoux, Philippe ^a,b,c   Servais, Stéphane ^a,b   Couet, Charles ^a,b,c  

^a CHRU de Tours   (France)

^b UNIVERSITÉ DE TOURS   (France)

^c CHU BRETONNEAU   (France)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; DOCOSAHEXAENOIC ACID; FISH OIL; ICOSAPENTAENOIC ACID; INTERLEUKIN 6; OMEGA 3 FATTY ACID; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANOREXIA; ARTICLE; BLOOD LEVEL; BODY FAT; BODY WEIGHT; CACHEXIA; CARCINOMATOUS PERITONITIS; CONTROLLED STUDY; FOOD INTAKE; HYPERMETABOLISM; LIPID COMPOSITION; MALE; NONHUMAN; ORGAN WEIGHT; RAT; SKELETAL MUSCLE; WHITE ADIPOSE TISSUE;

RATTUS;

EID: 77951124022     PISSN: 01635581     EISSN: None     Source Type: Journal    
DOI: 10.1080/01635580903407080     Document Type: Article

References (44)

1. Pfitzenmaier J, Vessella R, Higano CS, Noteboom JL, Wallace D, et al.: Elevation of cytokine levels in cachectic patients with prostate carcinoma. Cancer 97, 1211-1216, 2003.
2. Morley JE, Thomas DR, and Wilson MM: Cachexia: pathophysiology and clinical relevance. Am J Clin Nutr 83, 735-743, 2006.
3. Strassmann G, Fong M, Kenney JS, and Jacob CO: Evidence for the involvement of interleukin 6 in experimental cancer cachexia. J Clin Invest 89, 1681-1684, 1992.
4. Kayacan O, Karnak D, Beder S, Gullu E, Tutkak H, et al.: Impact of TNF-alpha and IL-6 levels on development of cachexia in newly diagnosed NSCLC patients. Am J Clin Oncol 29, 328-335, 2006.
5. Tisdale MJ: Wasting in cancer. J Nutr 129, 243S-246S, 1999.
6. Tisdale MJ: Molecular pathways leading to cancer cachexia. Physiology (Bethesda) 20, 340-348, 2005.
7. Camps C, Iranzo V, Bremnes RM, and Sirera R: Anorexia-cachexia syndrome in cancer: implications of the ubiquitin-proteasome pathway. Support Care Cancer 14, 1173-1183, 2006.
8. Saini A, Al-Shanti N, and Stewart CE: Waste management-cytokines, growth factors, and cachexia. Cytokine Growth Factor Rev 17, 475-486, 2006.
9. Falconer JS, Fearon KC, Ross JA, Elton R,Wigmore SJ, et al.: Acute-phase protein response and survival duration of patients with pancreatic cancer. Cancer 75, 2077-2082, 1995.
10. McMillan DC, Scott HR,Watson WS, Preston T, Milroy R, et al.: Longitudinal study of body cell mass depletion and the inflammatory response in cancer patients. Nutr Cancer 31, 101-105, 1998.
11. Fearon KC, Voss AC, and Hustead DS: Definition of cancer cachexia: effect of weight loss, reduced food intake, and systemic inflammation on functional status and prognosis. Am J Clin Nutr 83, 1345-1350, 2006.
12. Argiles JM, Lopez-Soriano FJ, and Busquets S: Emerging drugs for cancer cachexia. Expert Opin Emerg Drugs 12, 555-570, 2007.
13. Topkan E, Yavuz AA, and Ozyilkan O: Cancer cachexia: pathophysiologic aspects and treatment options. Asian Pac J Cancer Prev 8, 445-451, 2007.
14. Colomer R,Moreno-Nogueira JM, Garcia-Luna PP, García-Peris P, Garcíade-Lorenzo A, et al.: N-3 fatty acids, cancer and cachexia: a systematic review of the literature. Br J Nutr 97, 823-831, 2007.
15. Dewey A, Baughan C, Dean T, Higgins B, and Johnson I: Eicosapentaenoic acid (EPA, an omega-3 fatty acid from fish oils) for the treatment of cancer cachexia. Cochrane Database Syst Rev 1, CD004597, 2007.
16. Tan BH and Fearon KC: Cachexia: prevalence and impact in medicine. Curr Opin Clin Nutr Metab Care 11, 400-407, 2008.
17. Togni V, Ota CC, Folador A, J́unior OT, Aikawa J, et al.: Cancer cachexia and tumor growth reduction inWalker 256 tumor-bearing rats supplemented with n-3 polyunsaturated fatty acids for one generation. Nutr Cancer 46, 52-58, 2003.
18. Folador A, Hirabara SM, Bonatto SJ, Aikawa J, Yamazaki RK, et al.: Effect of fish oil supplementation for two generations on changes in macrophage function induced by Walker 256 cancer cachexia in rats. Int J Cancer 120, 344-350, 2007.
19. Cremades O, Parrado J, Jover M, Collantes de Teran L, Gutierrez JF, et al.: Nutritional treatment of cancer cachexia in rats. Use of a diet formulated with a crayfish enzymatic extract. Eur J Nutr 46, 347-353, 2007.
20. Dagnelie PC, Bell JD, Williams SC, Bates TE, Abel PD, et al.: Effect of fish oil on cancer cachexia and host liver metabolism in rats with prostate tumors. Lipids 29, 195-203, 1994.
21. Jho DH, Babcock TA, Tevar R, HeltonWS, and Espat NJ: Eicosapentaenoic acid supplementation reduces tumor volume and attenuates cachexia in a rat model of progressive non-metastasizing malignancy. JPEN J Parenter Enteral Nutr 26, 291-297, 2002. (Pubitemid 34913118)
22. Gunderson L and Sosin H: Adenocarcinoma of the stomach: areas of failure in a reoperation series (second or symptomatic look) clinicopathologic correlation and implications for adjuvant therapy. Int J Radiat Oncol Biol Phys 8, 1-11, 1982.
23. Hamazoe R,Maeta M, andKaibara N: Intraperitoneal thermochemotherapy for prevention of peritoneal recurrence of gastric cancer. Cancer 73, 2048-2051, 1994.
24. Ikeguchi M, Kondou A, Oka A, Tsujitani S, MaetaM, et al.: Effects of continuous hyperthermic peritoneal perfusion on prognosis of gastric cancer with serosal invasion. Eur J Surg 161, 581-586, 1995.
25. Martin F, Caignard A, Jeannin JF, Leclerc A, and Martin M: Selection by trypsin of two sublines of rat colon cancer cells forming progressive or regressive tumors. Int J Cancer 32, 623-627, 1983.
26. Caignard A, Martin MS, Michel MF, and Martin F: Interaction between two cellular subpopulations of a rat colonic carcinoma when inoculated to the syngeneic host. Int J Cancer 36, 273-279, 1985.
27. Zennadi R, Garrigue L, Ringeard S, Menoret A, Blanchardie P, et al.: Analysis of factors associated with the tumorigenic potential of 12 tumor clones derived from a single rat colon adenocarcinoma. Int J Cancer 52, 934-940, 1992.
28. Labarrìere N, Piau JP, Otry C, Denis M, Lustenberger P, et al.: H blood group antigen carried by CD44V modulates tumorigenicity of rat colon carcinoma cells. Cancer Res 54, 6275-6281, 1994.
29. Folch J, Lees M, and Sloane Stanley GH: A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 226, 497-509, 1957.
30. Emery PW: Cachexia in experimental models. Nutrition 15, 600-603, 1999.
31. Zhou S, Wang G, Chen B, and Wang P: Effect of dietary fatty acids on tumorigenesis of colon cancer induced by methyl nitrosourea in rats. J Environ Pathol Toxicol Oncol 19, 81-86, 2000.
32. Pizato N, Bonatto S, Yamazaki RK, Aikawa J, Nogata C, et al.: Ratio of n6 to n-3 fatty acids in the diet affects tumor growth and cachexia in Walker 256 tumor-bearing rats. Nutr Cancer 53, 194-201, 2005.
33. Ramos EJ, Middleton FA, Laviano A, Sato T, Romanova I, et al.: Effects of omega-3 fatty acid supplementation on tumor-bearing rats. J Am Coll Surg 199, 716-723, 2004.
34. Fearon KC: Cancer cachexia: developing multimodal therapy for a multidimensional problem. Eur J Cancer 44, 1124-1132, 2008.
35. Van Cutsem E and Arends J: The causes and consequences of cancerassociated malnutrition. Eur J Oncol Nurs 9, S51-S63, 2005.
36. Catalano MG, Fortunati N, Arena K, Costelli P, Aragno M, et al.: Selective up-regulation of tumor necrosis factor receptor I in tumor-bearing rats with cancer-related cachexia. Int J Oncol 23, 429-436, 2003.
37. Barber MD, Ross JA, and Fearon KC: Changes in nutritional, functional, and inflammatory markers in advanced pancreatic cancer. Nutr Cancer 35, 106-110, 1999.
38. Ramsey JJ, Harper ME, and Weindruch R: Restriction of energy intake, energy expenditure, and aging. Free Radic Biol Med 29, 946-968, 2000.
39. Odedra BR, Bates PC, and Millward DJ: Time course of the effect of catabolic doses of corticosterone on protein turnover in rat skeletal muscle and liver. Biochem J 214, 617-627, 1983.
40. Dumas JF, Simard G, RousselD,DouayO, Foussard F, et al.:Mitochondrial energy metabolism in a model of undernutrition induced by dexamethasone. Br J Nutr 90, 969-977, 2003.
41. Roussel D, Dumas JF, Augeraud A, Douay O, Foussard F, et al.: Dexamethasone treatment specifically increases the basal proton conductance of rat liver mitochondria. FEBS Lett 541, 75-79, 2003.
42. Rolfe DF and Brown GC: Cellular energy utilization and molecular origin of standard metabolic rate in mammals. Physiol Rev 77, 731-758, 1997.
43. Ryden M and Arner P: Fat loss in cachexia-is there a role for adipocyte lipolysis? Clin Nutr 26, 1-6, 2007.
44. Lieffers JR, Mourtzakis M, Hall KD, McCargar LJ, Prado CM, et al.: A viscerally driven cachexia syndrome in patients with advanced colorectal cancer: contributions of organ and tumor mass to whole-body energy demands. Am J Clin Nutr 89, 1173-1179, 2009.